66 results
Page 2 of 4
424B5
29kfoyt6
28 May 20
Prospectus supplement for primary offering
12:00pm
20-F/A
1wgvlrxgzpkwug5uu
30 Jul 19
Annual report (foreign) (amended)
7:00am
20-F/A
xspao2q37l2s
5 Jun 19
Annual report (foreign) (amended)
7:00am
6-K
EX-1
pxx4g
28 May 19
Current report (foreign)
7:04am
6-K
EX-99
2te d9rs81l294e
7 Feb 19
As Representative of the several Underwriters
12:00pm
424B5
cq2i8z yfy2x
5 Feb 19
Prospectus supplement for primary offering
5:12pm
424B5
ee2156nutuxvs 9k
4 Feb 19
Prospectus supplement for primary offering
5:52pm
F-3
EX-5.1
be5t2 d36
26 Dec 18
Shelf registration (foreign)
4:11pm
F-3
cw0tjruc7yfilf3on80
26 Dec 18
Shelf registration (foreign)
4:11pm
6-K
EX-99
njet38pg
8 Nov 18
BioLineRx Reports Significant Progress Across Oncology
7:00am
6-K
EX-99
51nj7 qb3
8 Nov 18
BioLineRx Reports Significant Progress Across Oncology
7:00am
6-K
EX-10.3
zhqy3l0t5g1tcvsxssip
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-10.4
15f33d
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
iy6wu uzpyymahokl
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
20-F/A
EX-4.33
k4iraiw8h
31 May 16
Annual report (foreign) (amended)
12:00am